TY - JOUR
T1 - A nationwide epidemiologic, clinical, genetic study of Usher syndrome in Japan
AU - The Interactable Hearing Disorder Consortium
AU - Yoshimura, Hidekane
AU - Nishio, Shin ya
AU - Isaka, Yuichi
AU - Kurokawa, Toru
AU - Usami, Shin ichi
AU - Akihiro, Katada
AU - Ogasawara, Noriko
AU - Shintani, Tomoko
AU - Kobayashi, Yumiko
AU - Sato, Hiroaki
AU - Kakehata, Seiji
AU - Kikuchi, Daisuke
AU - Ikezono, Tetsuo
AU - Ishikawa, Kotaro
AU - Shirai, Kyoko
AU - Takahashi, Masahiro
AU - Iwasaki, Satoshi
AU - Arai, Yasuhiro
AU - Sano, Hajime
AU - Okami, Mayuri
AU - Nakanishi, Hiroshi
AU - Esaki, Tomoko
AU - Sone, Michihiko
AU - Nakayama, Jun
AU - Okano, Takayuki
AU - Ota, Yumi
AU - Nishimura, Hiroshi
AU - Naito, Yasushi
AU - Kataoka, Yuko
AU - Sugaya, Akiko
AU - Maeda, Yukihide
AU - Masuda, Shin
AU - Sugawara, Kazuma
AU - Yamashita, Hiroshi
AU - Hato, Naoto
AU - Nakagawa, Takashi
AU - Ganaha, Akira
AU - Tono, Tetsuya
AU - Miyanohara, Ikuyo
AU - Suzuki, Mikio
N1 - Funding Information:
This research was funded by a Health and Labor Sciences Research Grant for Research on Rare and Intractable Diseases and Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labor and Welfare of Japan [S.U.: H29-Nanchitou(Nan)-Ippan-H31, 20FC1048], and a Grant-in-Aid from the Japan Agency for Medical Research and Development (AMED) [S.U.:16kk0205010h0001, 17kk0205010h0002, 18kk0205010h0003, 18ek0109363h0001, 19ek0109363h0002, 20ek0109363h0003]. We would like to thank the participants of the Interactable Hearing Disorder Consortium: Dr. Katada Akihiro (Asahikawa Medical University), Drs. Noriko Ogasawara and Tomoko Shintani (Sapporo Medical University), Drs. Yumiko Kobayashi and Hiroaki Sato (Iwate Medical University), Dr. Seiji Kakehata (Yamagata University), Dr. Daisuke Kikuchi (Fukushima Medical University), Dr. Tetsuo Ikezono (Saitama Medical University), Dr. Kotaro Ishikawa (National Rehabilitation Center), Dr. Kyoko Shirai (Tokyo Medical University), Drs. Masahiro Takahashi and Satoshi Iwasaki (International University of Health and Welfare), Dr. Yasuhiro Arai (Yokohama City University), Dr. Hajime Sano (Kitasato Univerisity), Dr. Mayuri Okami (Tokai University), Dr. Hiroshi Nakanishi (Hamamatsu University School of Medicine), Dr. Tomoko Esaki (Aichi Children's Health and Medical Center), Dr. Michihiko Sone (Nagoya Univerisity), Dr. Jun Nakayama (Shiga University of Medical Science), Dr. Takayuki Okano (Kyoto University), Dr. Yumi Ota (Osaka University), Dr. Hiroshi Nishimura (National Hospital Organization Osaka National Hospital), Dr. Yasushi Naito (Kobe City Medical Center General Hospital), Drs. Yuko Kataoka, Akiko Sugaya and Yukihide Maeda (Okayama University), Dr. Shin Masuda (Hiroshima Prefectual Hospital), Drs. Kazuma Sugawara and Hiroshi Yamashita (Yamaguchi University), Dr. Naoto Hato (Ehime University), Dr. Takashi Nakagawa (Kyusyu University), Drs. Akira Ganaha and Tetsuya Tono (Miyazaki University), Dr. Ikuyo Miyanohara (Kagoshima University), Dr. Mikio Suzuki (Ryukyu University).
Publisher Copyright:
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021
Y1 - 2021
N2 - Background: Usher syndrome (USH) typically leads to deaf-blindness, requiring the provision of extensive education and rehabilitation services. Therefore, investigating the prevalence is crucial to requests for proper government support for USH patients. Objective: The aim was to perform a nationwide epidemiologic survey of USH in Japan to estimate the prevalence of USH and reveal the relative frequency and characteristics of the three USH subtypes. Methods: To estimate the number of USH patients visiting hospitals over a 1-year period, 1,628 hospitals were randomly selected from all Departments of Otorhinolaryngology and Ophthalmology in Japan. Subsequently, we collected data regarding the clinical characteristics of each patient treated and the results of genetic testing, if performed. Results: We found that the prevalence of USH was at least 0.4 per 100,000 population. The frequency of clinical subtypes and causal genes for USH were consistent with previous reports. Also, we demonstrated the feasibility of genetic counseling for USH patients based on the results of genetic testing. Conclusion: USH is a rare disease, but requires social support due to the severity of symptoms. To minimize these issues, understanding the clinical characteristics and performing comprehensive genetic testing could allow early and accurate diagnosis as well as medical intervention.
AB - Background: Usher syndrome (USH) typically leads to deaf-blindness, requiring the provision of extensive education and rehabilitation services. Therefore, investigating the prevalence is crucial to requests for proper government support for USH patients. Objective: The aim was to perform a nationwide epidemiologic survey of USH in Japan to estimate the prevalence of USH and reveal the relative frequency and characteristics of the three USH subtypes. Methods: To estimate the number of USH patients visiting hospitals over a 1-year period, 1,628 hospitals were randomly selected from all Departments of Otorhinolaryngology and Ophthalmology in Japan. Subsequently, we collected data regarding the clinical characteristics of each patient treated and the results of genetic testing, if performed. Results: We found that the prevalence of USH was at least 0.4 per 100,000 population. The frequency of clinical subtypes and causal genes for USH were consistent with previous reports. Also, we demonstrated the feasibility of genetic counseling for USH patients based on the results of genetic testing. Conclusion: USH is a rare disease, but requires social support due to the severity of symptoms. To minimize these issues, understanding the clinical characteristics and performing comprehensive genetic testing could allow early and accurate diagnosis as well as medical intervention.
UR - http://www.scopus.com/inward/record.url?scp=85117369913&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117369913&partnerID=8YFLogxK
U2 - 10.1080/00016489.2021.1966500
DO - 10.1080/00016489.2021.1966500
M3 - Article
C2 - 34452594
AN - SCOPUS:85117369913
SN - 0001-6489
VL - 141
SP - 841
EP - 846
JO - Acta Oto-Laryngologica
JF - Acta Oto-Laryngologica
IS - 9
ER -